Medeon Biodesign Inc Stock Taipei Exchange
Equities
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- | - |
05-10 | Medeon Biodesign, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-08 | Medeon Biodesign, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2022 | 298M 9.19M 0 12.51M | Sales 2023 | 196M 6.05M 0 8.23M | Capitalization | 4.29B 132M 0 180M |
---|---|---|---|---|---|
Net income 2022 | -434M -13.37M - -18.2M | Net income 2023 | -1.2B -37.12M - -50.52M | EV / Sales 2022 | 12.5 x |
Net cash position 2022 | 1.35B 41.54M 0 56.53M | Net cash position 2023 | 1.96B 60.23M 0 81.97M | EV / Sales 2023 | 11.9 x |
P/E ratio 2022 |
-11.7
x | P/E ratio 2023 |
-3.56
x | Employees | - |
Yield 2022 |
0.86% | Yield 2023 |
-
| Free-Float | 47.57% |
Managers | Title | Age | Since |
---|---|---|---|
Yu Te Chang
CEO | Chief Executive Officer | - | 12-12-21 |
Ching Yi Chen
DFI | Director of Finance/CFO | - | - |
Greta Chang
PRN | Corporate Officer/Principal | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Yu Te Chang
CEO | Chief Executive Officer | - | 12-12-21 |
Chih Lung Shen
BRD | Director/Board Member | 59 | 15-04-19 |
Hong Jen Chang
BRD | Director/Board Member | 68 | 14-01-13 |
1st Jan change | Capi. | |
---|---|---|
+7.01% | 217B | |
+11.01% | 190B | |
+19.20% | 143B | |
+30.79% | 111B | |
+1.48% | 64.59B | |
+13.95% | 52.36B | |
-0.16% | 48.45B | |
-6.20% | 38.03B | |
+0.91% | 35.61B |